Molecular Detection of pulmonary Tuberculosis using the Gene X pert MTB/RIF assay in Kurdistan of Iraq

Molecular Detection of pulmonary Tuberculosis using the Gene X pert MTB/RIF assay in Kurdistan of Iraq

Tuberculosis has been potentially diagnosed by an innovative Gene Xpert Mycobacterium tuberculosis refampcin tool substantially impacted the quick detection of RIF resistance in clinical samples, Multi drug-resistant tuberculosis signify the remarkable resistance to the conventional (isoniazid, rifa...

Full description

Bibliographic Details
Main Author:	Bushra Karim Xoshnaw
Format:	Article
Language:	English
Published:	Salahaddin University-Erbil 2019-02-01
Series:	Zanco Journal of Pure and Applied Sciences
Subjects:	Mycobacterium tuberculosis (MTB) rifampicin resistance multi-drug resistance (MDR)
Online Access:	http://zancojournals.su.edu.krd/index.php/JPAS/article/view/2475

Similar Items

Xpert MTB/RIF for rapid detection of rifampicin-resistant Mycobacterium tuberculosis from pulmonary tuberculosis patients in Southwest Ethiopia
by: Mulualem Tadesse, et al.
Published: (2016-01-01)

An evaluation of false-positive rifampicin resistance on the Xpert MTB/RIF
by: Yeliz Tanriverdi Cayci, et al.

Diagnostic utility of GeneXpert MTB/RIF assay versus conventional methods for diagnosis of pulmonary and extra-pulmonary tuberculosis
by: Asmaa Mohammed Elbrolosy, et al.
Published: (2021-05-01)

Age and sex distribution of Mycobacterium tuberculosis infection and rifampicin resistance in Myanmar as detected by Xpert MTB/RIF
by: Marva Seifert, et al.
Published: (2021-08-01)

Phenotypic drug susceptibility characterization and clinical outcomes of tuberculosis strains with A-probe mutation by GeneXpert MTB/RIF
by: Qi Nie, et al.
Published: (2023-11-01)

Rifampicin Resistance by Xpert MTB/RIF Assay in Pulmonary Tuberculosis- Is there a Need for Confirmation by Retesting?
by: Swapna Rajesh Kanade, et al.
Published: (2022-05-01)

Performance of Xpert® MTB/RIF among tuberculosis outpatients in Lilongwe, Malawi
by: Tarsizio Chikaonda, et al.
Published: (2017-03-01)

GeneXpert MTB/RIF Ultra performance to detect uncommon rpoB mutations in Mycobacterium tuberculosis
by: Leen Rigouts, et al.
Published: (2023-07-01)

Magnitude of Mycobacterium tuberculosis Infection and Its Resistance to Rifampicin Using Xpert-MTB/RIF Assay Among Presumptive Tuberculosis Patients at Motta General Hospital, Northwest Ethiopia
by: Demissie TA, et al.
Published: (2021-04-01)

Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia
by: Julia V. Ershova, et al.
Published: (2020-07-01)

A comparative study of AFB smear and GeneXpert MTB/RIF assay in pulmonary and extrapulmonary specimens and detection of rifampicin resistance in a tertiary care hospital
by: Pragya, et al.
Published: (2017-10-01)

Prevalence, Associated Risk Factors and Rifampicin Resistance Pattern of Pulmonary Tuberculosis Among Children at Debre Markos Referral Hospital, Northwest, Ethiopia
by: Liyew Ayalew M, et al.
Published: (2020-10-01)

Pulmonary Tuberculosis and Rifampicin Resistant Mycobacterium Tuberculosis in Children and Adolescents using Gene Xpert MTB/RIF Assay in Tigray, Northern Ethiopia
by: Dejene TA, et al.
Published: (2023-10-01)

Xpert MTB/RIF assay for the diagnosis of rifampicin resistance in different regions: a meta-analysis
by: Kaican Zong, et al.
Published: (2019-08-01)

Distribution and Frequency of rpoB Mutations Detected by Xpert MTB/RIF Assay Among Beijing and Non-Beijing Rifampicin Resistant Mycobacterium tuberculosis Isolates in Bangladesh
by: Uddin MKM, et al.
Published: (2020-03-01)

Line-probe assay and molecular typing reveal a potential drug resistant clone of Mycobacterium tuberculosis in Ethiopia
by: Shiferaw Bekele, et al.
Published: (2018-12-01)

Occurrence rate of rifampicin-resistant Mycobacterium tuberculosis in patients attending chest clinics in selected hospitals in Akure metropolis
by: Saheed Jegede, et al.
Published: (2022-10-01)

Performance of the Abbott RealTime MTB RIF/INH resistance assay when used to test Mycobacterium tuberculosis specimens from Bangladesh
by: Kostera J, et al.
Published: (2018-05-01)

Evaluation of Xpert MTB/RIF assay performance in the diagnosis of abdominal tuberculosis
by: Suraj Kumar, et al.
Published: (2017-04-01)

Trends of Mycobacterium tuberculosis and Rifampicin resistance in Northwest Ethiopia: Xpert® MTB/RIF assay results from 2015 to 2021
by: Sirak Biset, et al.
Published: (2024-02-01)

Comparison of Interpretation between Pyrosequencing and Xpert MTB/RIF Assay in Multidrug-Resistant Tuberculosis
by: Linda Choerunnisa, et al.
Published: (2020-12-01)

Integrating Molecular Diagnostics and GIS Mapping: A Multidisciplinary Approach to Understanding Tuberculosis Disease Dynamics in South Africa Using Xpert MTB/RIF
by: Lesley Erica Scott, et al.
Published: (2023-10-01)

Diagnosis of tuberculosis from smear-negative presumptive TB cases using Xpert MTB/Rif assay: a cross-sectional study from Nepal
by: Priyatam Khadka, et al.
Published: (2019-12-01)

Role of GeneXpert MTB/RIF assay for the diagnosis of cervical lymph node tuberculosis and rifampicin resistance
by: Sahjid Mukhida, et al.
Published: (2022-01-01)

Diagnostic performance of GeneXpert MTB/RIF in detecting MTB in smear-negative presumptive TB patients
by: Raksha Rimal, et al.
Published: (2022-04-01)

Trends in the incidence of Rifampicin resistant Mycobacterium tuberculosis infection in northeastern Nigeria
by: Muhammad M. Ibrahim, et al.
Published: (2022-09-01)

Diagnostic Efficacy of Xpert MTB/RIF Assay in Bronchoalveolar Lavage Fluid for Tracheobronchial Tuberculosis: A Retrospective Analysis
by: Yue Sun, et al.
Published: (2021-08-01)

Identification of Mycobacterium tuberculosis and Rifampin Resistance in Pulmonary and Extra-pulmonary Clinical Specimens Using the Gene Xpert MTB/RIF Assay
by: Fahimeh Azadi, et al.
Published: (2021-07-01)

Detection of Mycobacterium tuberculosis Rifampicin Resistance Conferred by Borderline rpoB Mutations: Xpert MTB/RIF is Superior to Phenotypic Drug Susceptibility Testing
by: Xia H, et al.
Published: (2022-03-01)

Characterization of Genetic Variants Associated with Rifampicin Resistance Level in Mycobacterium tuberculosis Clinical Isolates Collected in Guangzhou Chest Hospital, China
by: Hameed HMA, et al.
Published: (2022-09-01)

Prevalence of rifampicin resistant Mycobacterium tuberculosis among presumptive tuberculosis patients in selected governmental hospitals in Addis Ababa, Ethiopia
by: Balew Arega, et al.
Published: (2019-04-01)

Does Xpert® MTB/RIF assay give rifampicin resistance results without identified mutation? Review of cases from Addis Ababa, Ethiopia
by: Ayinalem Alemu, et al.
Published: (2020-01-01)

Evaluation of GeneXpert MTB/RIF for determination of rifampicin resistance among new tuberculosis cases in west and northwest Iran
by: S. Atashi, et al.
Published: (2017-09-01)

Role of Culture Free Rapid ImmunoAssay (ELISA) and Genexpert (MTB/RIF) Technology in the Diagnosis of Tuberculosis
by: Shahida Hussain, et al.
Published: (2024-01-01)

Role of Culture Free Rapid ImmunoAssay (ELISA) and Genexpert (MTB/RIF) Technology in the Diagnosis of Tuberculosis
by: Shahida Hussain, et al.
Published: (2024-01-01)

COMPARATIVE ANALYSIS OF MTB STRAINS WITH DIFFERENT TYPES OF DRUG RESISTANCE IN PULMONARY TUBERCULOSIS IN THE KYRGYZ REPUBLIC
by: A.A. TOKTOGONOVA, et al.
Published: (2018-08-01)

A feasibility study of the Xpert MTB/RIF test at the peripheral level laboratory in China
by: Xichao Ou, et al.
Published: (2015-02-01)

Variations in rifampicin and isoniazid resistance associated genetic mutations among drug naïve and recurrence cases of pulmonary tuberculosis
by: Saba Kabir, et al.
Published: (2021-02-01)

Efficiency of Genexpert MTB/RIF in Patients with Newly Diagnosed and Recurrent Pulmonary Tuberculosis
by: Ye.N. Raznatovskaia, et al.
Published: (2015-04-01)

Diagnostic Performance of Xpert MTB/RIF Ultra Compared with Predecessor Test, Xpert MTB/RIF, in a Low TB Incidence Setting: a Retrospective Service Evaluation
by: Mary Mansfield, et al.
Published: (2022-06-01)